The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

BXP BEXIMCO PHARMACEUTICALS LIMITED GDR (EACH REPR 1 ORD BDT10)(REGS)




Time/Date Code Headline Source Impact
07:00 09-May-2016 BXP Final Results RNS +7.78% Up
07:01 06-May-2016 BXP AGM Change and Dividend Update RNS +5.70% Up
07:00 06-May-2016 BXP Change of Accounting Reference Date RNS +5.70% Up
07:00 04-May-2016 BXP Amendment to Notification of Preliminary Results RNS +1.68% Up
07:00 21-Apr-2016 BXP Notification of Preliminary Results and AGM RNS +5.44% Up
07:00 19-Nov-2015 BXP US FDA approval to manufacture blood pressure drug RNS +11.65% Up
07:00 27-Oct-2015 BXP 3rd Quarter Results RNS -2.02% Down
07:00 24-Jul-2015 BXP Half Yearly Report RNS +5.13% Up
10:53 13-Jul-2015 BXP Payment of Cash Dividend RNS -0.84% Down
07:00 26-Jun-2015 BXP Stock Dividend Issued and Total Voting Rights RNS +3.84% Up
07:00 24-Jun-2015 BXP Beximco Pharma receives US FDA approval RNS +6.57% Up
07:00 15-Jun-2015 BXP AGM Statement RNS -


Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 17 Dhanmondi R/A, Road No. 2, Dhaka, 1205, Bangladesh
Company website http://www.beximco-phar...
Market cap(in millions)* £ 98.11
Listing/Admission to trading 21 Oct 2005
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
24-May-16
FTSE index -
FTSE sector -
FTSE sub-sector -
Country of share register US
Segment AIMI
MiFID Status MTF
Exchange market size 5,000
SEDOL B0DM5S5
ISIN number US0885792061



BEXIMCO PHARMA share news analysis (BXP)